2Lorenzi M.Glucose toxicity in the vascular complications of diabetes: the cellular perspective[J],1992(08).
3Nabel EG.Biology of the impaired endothelium,1997(12).
4James GM;Hodgson WC.A role for protein kinase C in the attenuated response to 5 - hydmxytryptamine in aortas from streptozotocin- diabetic rats,1997(01).
5Kliniki Okulistycznej AM w Bialymstoku.Serotonin in diabetic retinopathy,1996(02).
2Arden GB, Sivaprasad S. The pathogenesis of early retinal changes of diabetic retinopathy[ J 1- Doc Ophthalmol, 2012, 124 : 15 - 26.
3Romanova GA, Kvashennikova YN, Shakova FM, et al. Effect of antibodies to glutamate on the content of neurotransmitter amino acids in brain structures of rats with ischemic damage to the prefron- tal cortex[ J ]. Bull Exp Biol Med, 2012, 153 : 13 - 15.
4Harris A, Arend O, Danis RP, et al. Hyperoxia improves contrast sensitivity in early diabetic retinopathy [ J ]. Br J Ophthalmol, 1996, 80:209-213.
5Drasdo N, Chiti Z, Owens DR, et al. Effect of darkness on inner retinal hypoxia in diabetes[ J ]. Lancet, 2002, 359:2251 - 2253.
6Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspec- tives[J]. Rev Endocr Metab Disord, 2008, 9:315 -327.
7Yoles E, Schwartz M. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve [ J ]. Arch Ophthalmol, 1998, 116:906 - 910.
8Opere CA, Ford K, Zhao M, et al. Regulation of neurotransmitter release from ocular tissues by isoprostanes [ J]. Methods Find Exp Clin Pharmacol, 2008, 30:697 - 701.
9Leng G, Ludwig M. Neurotransmitters and peptides: whispered se- crets and public announcements [ J ]. J Physiol, 2008, 586 ( Pt 23 ) :5625 - 532.
10Sucher N J, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cell [ J ]. Vis Res, 1997, 37 : 3483 - 3493.
